New Charging Arrangement for Company-Sponsored Amendment on 01 January 2022

  • January 1, 2022

New Charging Arrangement for Company-Sponsored Amendment on 01 January 2022

This is to announce that the Joint CUHK-NTEC CREC will implement the charging arrangement for company-sponsored clinical trial when submitting Protocol Amendment.

For signification changes to the Study Protocol that require the Joint CUHK-NTEC CREC to perform another full review, the Joint CUHK-NTEC CREC will charge the sponsor HK$14,000 for such a review according to HA Memo dated 04 September 2017.